105 related articles for article (PubMed ID: 406220)
1. [Glutarladehyde-pollen-tyrosine hyposensitization. Course control of therapy using RIST and RAST].
Jarisch R
Hautarzt; 1977 Apr; 28(4):185-7. PubMed ID: 406220
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunologic tests in specific immunotherapy of atopic rhinitis].
Ligeziński A
Wiad Lek; 1984 Dec; 37(23):1846-50. PubMed ID: 6442498
[No Abstract] [Full Text] [Related]
3. [New possibilities of hyposensitization with pollen-l-tyrosine complexes (author's transl)].
Horak F
Laryngol Rhinol Otol (Stuttg); 1978 Nov; 57(11):961-5. PubMed ID: 723401
[TBL] [Abstract][Full Text] [Related]
4. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy with glutaraldehyde treated tyrosine adsorbed grass pollen in the treatment of allergic rhinitis.
Small P; Shapiro M
Ann Allergy; 1981 Dec; 47(6):443-5. PubMed ID: 6798900
[No Abstract] [Full Text] [Related]
6. [Comparison of 3 types of immunotherapy for treating grass pollen-induced allergic rhinitis].
Hébert J; Bédard PM
Allerg Immunol (Paris); 1986 Sep; 18(7):19-23. PubMed ID: 3453720
[TBL] [Abstract][Full Text] [Related]
7. [Immunological and clinical studies on the pollen-L-tyrosin complexes in hyposensitization therapy].
Horak F
Wien Med Wochenschr; 1977 Nov; 127(22):677-81. PubMed ID: 595610
[No Abstract] [Full Text] [Related]
8. [Hyposensitization with cross-reacting pollen allergens].
Karl S; Rakoski J
Z Hautkr; 1988; 63 Suppl 4():55-7. PubMed ID: 3252627
[TBL] [Abstract][Full Text] [Related]
9. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
10. [Case of pollinosis to grass pollens who presented with dyspnea successfully treated by rush immunotherapy].
Kawada Y; Takamasu T; Inuo C; Aikawa H; Kurihara K
Arerugi; 2007 Nov; 56(11):1403-7. PubMed ID: 18059155
[TBL] [Abstract][Full Text] [Related]
11. [How and when is immunotherapy for pollen allergy carried out?].
Kersten W
Med Klin; 1980 Oct; 75(21):751-4. PubMed ID: 7453622
[TBL] [Abstract][Full Text] [Related]
12. [Experiences with desensitization of early spring pollen allergy using 2 tree pollen extracts].
Henzgen M; Wenz W; Strümpfel R
Z Gesamte Inn Med; 1989 Nov; 44(22):691-3. PubMed ID: 2626850
[TBL] [Abstract][Full Text] [Related]
13. [Advantages of hyposensitization with a high dose of allergoid in pollen allergy].
Kuhn W; Urbanek R; Forster J; Schreyer H; Wais U
Klin Padiatr; 1983; 195(6):411-4. PubMed ID: 6656169
[TBL] [Abstract][Full Text] [Related]
14. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons].
Paranos S; Petrović S; Vojović I
Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408
[TBL] [Abstract][Full Text] [Related]
15. [The clinical significance of anti-IgE antibodies in the treatment of allergic rhinopathy].
Loidolt D; Vassella CC; de Weck AL; Stadler BM
Laryngorhinootologie; 1990 May; 69(5):255-9. PubMed ID: 2354019
[TBL] [Abstract][Full Text] [Related]
16. [IgE and IgG antibody response in patients with type I allergy to birch pollen].
Rumpold H; Jarolim E; Bonitz W; Tejkl M; Breitenbach M; Scheiner O; Kraft D
Wien Klin Wochenschr; 1989 Feb; 101(3):107-10. PubMed ID: 2922932
[TBL] [Abstract][Full Text] [Related]
17. PRIST, RAST, and beyond. Diagnosis and therapy.
Nalebuff DJ
Otolaryngol Clin North Am; 1985 Nov; 18(4):725-44. PubMed ID: 3909057
[TBL] [Abstract][Full Text] [Related]
18. IgG and IgE antibody response following Pollinex-R immunotherapy.
Ko HS; Chen SJ; Jaworska E
Ann Allergy; 1987 Dec; 59(6):441-9. PubMed ID: 3122605
[TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
